The effect of transforming growth factor-1 on nasopharyngeal carcinoma cells: Insensitive to cell growth but functional to TGF-/Smad pathway

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Xiao, Jian ^b   Xiang, Qi ^a   Xiao, Ye Chen ^a   Su, Zhi Jian ^a   Huang, Zhi Feng ^b   Zhang, Qi Hao ^a   Tan, Yi ^b   Li, Xiao Kun ^b   Huang, Ya Dong ^a  

^a JINAN UNIVERSITY   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; EPITHELIUM CELL; GENE EXPRESSION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; NASOPHARYNX CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STIMULATION; BIOSYNTHESIS; CARCINOMA; CELL PROLIFERATION; DOSE RESPONSE; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; NASOPHARYNX TUMOR; TIME; TUMOR CELL LINE;

CARCINOMA; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CYTOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; NASOPHARYNGEAL NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMAD PROTEINS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77951122853     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-35     Document Type: Article

References (41)

1. Concurrent chemoradiotherapy in the management of advanced nasopharyngeal carcinoma: current status. S Afqir N Ismaili H Errihani, J Cancer Res Ther 2009 5 3 7 10.4103/0973-1482.48763 19293481
2. Histological Typing of Tumours of the Upper Respiratory Tract and Ear. KSL Shanmugaratnam, WHO. World Health Organization. International Histological Classification of Tumours Berlin, Springer 2 1996
3. Incidence of nasopharyngeal carcinoma in Chinese immigrants, compared with Chinese in China and South East Asia: review. WM Yu SS Hussain, J Laryngol Otol 2009 123 1067 1074 10.1017/S0022215109005623 19486543
4. The aetiology of nasopharyngeal carcinoma. AL McDermott SN Dutt JC Watkinson, Clin Otolaryngol Allied Sci 2001 26 82 92 10.1046/j.1365-2273.2001. 00449.x 11309046
5. Epidemiology of nasopharyngeal carcinoma. MC Yu JM Yuan, Semin Cancer Biol 2002 12 421 429 10.1016/S1044579X02000858 12450728
6. Growth factors and receptors in juvenile nasopharyngeal angiofibroma and nasal polyps: an immunohistochemical study. PJ Zhang R Weber HH Liang TL Pasha VA LiVolsi, Arch Pathol Lab Med 2003 127 1480 1484 14567719
7. Proliferation, angiogenesis and hormonal markers in juvenile nasopharyngeal angiofibroma. G Saylam OT Yucel A Sungur M Onerci, Int J Pediatr Otorhinolaryngol 2006 70 227 234 10.1016/j.ijporl.2005.06.007 16023739
8. Change of plasma transforming growth factor-beta1 levels in nasopharyngeal carcinoma patients treated with concurrent chemo-radiotherapy. HW Chen YC Chang YL Lai YJ Chen MJ Huang YS Leu YK Fu LW Wang JJ Hwang, Jpn J Clin Oncol 2005 35 427 432 10.1093/jjco/hyi126 16006572
9. Association of transforming growth factor-beta1 gene polymorphisms with genetic susceptibility to nasopharyngeal carcinoma. YS Wei YH Zhu B Du ZH Yang WB Liang ML Lv XH Kuang SH Tai Y Zhao L Zhang, Clin Chim Acta 2007 380 165 169 10.1016/j.cca.2007.02.008 17368597
10. TGFbeta family signaling: novel insights in development and disease. K Wharton R Derynck, Development 2009 136 3691 3697 10.1242/dev.040584 19855012
11. The hallmarks of cancer. D Hanahan RA Weinberg, Cell 2000 100 57 70 10.1016/S0092-8674(00)81683-9 10647931
12. Differential regulation of TGF-beta signaling through Smad2, Smad3 and Smad4. A Kretschmer K Moepert S Dames M Sternberger J Kaufmann A Klippel, Oncogene 2003 22 6748 6763 10.1038/sj.onc.1206791 14555988
13. Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone. AA Mourskaia Z Dong S Ng M Banville JC Zwaagstra MD O'Connor-McCourt PM Siegel, Oncogene 2009 28 1005 1015 10.1038/onc.2008.454 19079339
14. The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domain. MP de Caestecker T Yahata D Wang WT Parks S Huang CS Hill T Shioda AB Roberts RJ Lechleider, J Biol Chem 2000 275 2115 2122 10.1074/jbc.275.3.2115 10636916
15. Transcriptional control by the TGF-beta/Smad signaling system. J Massague D Wotton, Embo J 2000 19 1745 1754 10.1093/emboj/19.8.1745 10775259
16. SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer. A Blackford OK Serrano CL Wolfgang G Parmigiani S Jones X Zhang DW Parsons JC Lin RJ Leary JR Eshleman M Goggins EM Jaffee CA Iacobuzio-Donahue A Maitra JL Cameron K Olino R Schulick J Winter JM Herman D Laheru AP Klein B Vogelstein KW Kinzler VE Velculescu RH Hruban, Clin Cancer Res 2009 15 4674 4679 10.1158/1078-0432.CCR-09-0227 19584151
17. Differential expression of multiple genes in association with MADH4/DPC4/SMAD4 inactivation in pancreatic cancer. D Cao R Ashfaq MG Goggins RH Hruban SE Kern CA Iacobuzio-Donahue, Int J Clin Exp 2008 1 510 517
18. Role of transforming growth factor-beta signaling pathway in pathogenesis of benign biliary stricture. ZM Geng JB Zheng XX Zhang J Tao L Wang, World J Gastroenterol 2008 14 4949 4954 10.3748/wjg.14.4949 18756605
19. Smad4/Smad7 balance: a role of tumorigenesis in gastric cancer. A Leng T Liu Y He Q Li G Zhang, Exp Mol Pathol 2009 87 48 53 10.1016/j.yexmp.2009.03.003 19341727
20. Regulation of TGF-beta signaling by Smad7. X Yan Z Liu Y Chen, Acta Biochim Biophys Sin 2009 41 263 272 10.1093/abbs/gmp018 19352540
21. Smad7 is inactivated through a direct physical interaction with the LIM protein Hic-5/ARA55. H Wang K Song TL Krebs J Yang D Danielpour, Oncogene 2008 27 6791 6805 10.1038/onc.2008.291 18762808
22. Controlling TGF-beta signaling. J Massague YG Chen, Genes Dev 2000 14 627 644 10733523
23. The Smad pathway. JL Wrana L Attisano, Cytokine Growth Factor Rev 2000 11 5 13 10.1016/S1359-6101(99)00024-6 10708948
24. Role of high-molecular weight tropomyosins in TGF-beta-mediated control of cell motility. Q Zheng A Safina AV Bakin, Int J Cancer 2008 122 78 90 10.1002/ijc.23025 17721995
25. Loss of p12CDK2-AP1 expression in human oral squamous cell carcinoma with disrupted transforming growth factor-beta Smad signaling pathway. H Peng S Shintani Y Kim DT Wong, Neoplasia 2006 8 1028 1036 10.1593/neo.06580 17217620
26. The significance of serum transforming growth factor beta 1 in detecting of gastric and colon cancers. S Coban O Yuksel MC Kockar S Koklu O Basar H Tutkak N Ormeci, Hepatogastroenterology 2007 54 1472 1476 17708279
27. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment. L Strauss C Bergmann M Szczepanski W Gooding JT Johnson TL Whiteside, Clin Cancer Res 2007 13 4345 4354 10.1158/1078-0432.CCR-07-0472 17671115
28. Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2. CA Muro-Cacho K Rosario-Ortiz S Livingston T Munoz-Antonia, Clin Cancer Res 2001 7 1618 1626 11410498
29. Mitogenic conversion of transforming growth factor-beta1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer. BJ Park JI Park DS Byun JH Park SG Chi, Cancer Res 2000 60 3031 3038 10850453
30. Smad2 and Smad4 gene mutations in hepatocellular carcinoma. MC Yakicier MB Irmak A Romano M Kew M Ozturk, Oncogene 1999 18 4879 4883 10.1038/sj.onc.1202866 10490821
31. Smad4-mediated TGF-beta signaling in tumorigenesis. G Yang X Yang, Int J Biol Sci 2010 6 1 8 20087440
32. A Smad transcriptional corepressor. D Wotton RS Lo S Lee J Massague, Cell 1999 97 29 39 10.1016/S0092-8674(00)80712-6 10199400
33. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. R Derynck YE Zhang, Nature 2003 425 577 584 10.1038/nature02006 14534577
34. Transforming growth factor beta 1 and androgen receptors in prostate neoplasia. MR Cardillo E Petrangeli L Salvatori L Ravenna F Di Silverio, Anal Quant Cytol Histol 2000 22 403 410 11064817
35. TGF-beta signaling in breast cancer. MB Buck C Knabbe, Ann N Y Acad Sci 2006 1089 119 26 10.1196/annals.1386.024 17261761
36. TGFbeta1 T29C polymorphism and cancer risk: a meta-analysis based on 40 case-control studies. BB Wei B Xi R Wang JM Bai JK Chang YY Zhang R Yoneda JT Su LX Hua, Cancer Genet Cytogenet 2010 196 68 75 10.1016/j.cancergencyto.2009.09. 016 19963138
37. TGF-beta1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer. S Araki JA Eitel CN Batuello K Bijangi-Vishehsaraei XJ Xie D Danielpour KE Pollok DA Boothman LD Mayo, J Clin Invest 2010 120 290 302 19955655
38. Role of transforming growth factor Beta in human cancer. RL Elliott GC Blobe, J Clin Oncol 2005 23 2078 2093 10.1200/JCO.2005.02.047 15774796
39. Transforming growth factor-beta1 (TGF-beta1) and acetylcholine (ACh) alter nitric oxide (NO) and interleukin-1beta (IL-1beta) secretion in human colon adenocarcinoma cells. R Paduch M Kandefer-Szerszẽ In Vitro Cell Dev Biol Anim 2009 45 543 550 10.1007/s11626-009-9220-7 19551451
40. 4-hydroxynonenal and TGF-beta1 concur in inducing antiproliferative effects on the CaCo-2 human colon adenocarcinoma cell line. B Vizio G Poli E Chiarpotto F Biasi, Biofactors 2005 24 237 246 10.1002/biof.5520240128 16403984
41. Differential gene expression in nasopharyngeal carcinoma cell with reduced and normal expression of 6A8 alpha-mannosidase. SL Chen Y Shi YL Jin Y Liu FT Zhao LP Zhu, Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2005 27 305 310 16038265